At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Subcutaneous Transplantation of Autologous Cell Enriched Adipose Tissue For Follicular Niche Stimulation in Early Stage Alopecia Androgenetica (STYLE): a Randomized, Blinded, Controlled Trial
In Brief
A clinical study evaluating Puregraft System, Celution System, and 2 other interventions for Alopecia, Androgenetic. Completed, enrolled 71 participants across 4 sites.
Detailed Summary
The primary objective of this study is to evaluate the safety and feasibility of the Celution and Puregraft Systems in the processing and preparation of an autologous fat graft enriched with adipose-derived regenerative cells (ADRCs) in the treatment of early alopecia androgenetica.
Study Details
Timeline
Interventions
The Puregraft System prepares purified adipose tissue for subcutaneous scalp injection.
The Celution System prepares adipose derived regenerative cells (ADRCs) for subcutaneous scalp injection.
The Kerastem Therapy is the subcutaneous scalp injection of purified adipose prepared with the Puregraft System enriched with ADRCs prepared from the Celution System.
Tissue collection involving the micro-harvest of subcutaneous adipose tissue.